Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Amoxicillin Sodium and Sulbactam Sodium for Injection

Approval Number

国药准字H20030202

Company江西东风药业股份有限公司

Registration Date

July 30, 2021

Previous Approval Numbers

国药准字H20030202

Drug Information

Generic Name

注射用阿莫西林钠舒巴坦钠

Trade Name

来切利

Brand Name

来切利

Dosage Form

注射剂

Strength

3.0g(C16H19N3O5S 2.0g与C8H11NO5S 1.0g)

Drug Type

化学药品

Registration Date

July 30, 2021

Company Information

Applicant Company

Company Name江西东风药业股份有限公司

Company Address

江西省景德镇市乐平市乐平工业园东风路1号

Manufacturing Company

Company Name江西东风药业股份有限公司

Company Address

江西省乐平市乐平工业园东风路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy